Co-infection with invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia after corticosteroid therapy

Journal of Infection and Chemotherapy

Volumn 19, Issue 2, 2013, Pages 342-347

  Hagiya, Hideharu ^a   Miyake, Takayoshi ^b   Kokumai, Yusuke ^b   Murase, Tomoko ^b   Kuroe, Yasutoshi ^a   Nojima, Hiroyoshi ^a   Sugiyama, Junichi ^a   Naito, Hiromichi ^a   Hagioka, Shingo ^a   Morimoto, Naoki ^a  

^a Tsuyama Central Hospital   (Japan)

^b Tsuyama Central Hospital   (Japan)

Author keywords

Coinfection; Corticosteroid therapy; Invasive pulmonary aspergillosis; Opportunistic infection; Pneumocystis jirovecii pneumonia

Indexed keywords

AMPHOTERICIN B; AZITHROMYCIN; BETA GLUCAN; CEFTRIAXONE; CORTICOSTEROID; COTRIMOXAZOLE; GALACTOMANNAN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN M; LEVOFLOXACIN; MEROPENEM; METHYLPREDNISOLONE; MINOCYCLINE; PREDNISOLONE; TRIMETHOPRIM;

ACUTE LUNG INJURY; AGED; ANTIBODY TITER; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMMUNITY ACQUIRED PNEUMONIA; COMPUTER ASSISTED TOMOGRAPHY; DETERIORATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG MEGADOSE; DRUG SAFETY; ENDOTRACHEAL INTUBATION; FEVER; HEPATITIS C; HUMAN; HYPOALBUMINEMIA; HYPOCOMPLEMENTEMIA; HYPOXEMIA; LEUKOCYTE COUNT; LIVER FUNCTION TEST; LUNG ASPERGILLOSIS; LUNG LAVAGE; MALE; MIXED INFECTION; MULTIPLE ORGAN FAILURE; PLEURA EFFUSION; PNEUMOCYSTIS JIROVECI; PNEUMOCYSTIS PNEUMONIA; PNEUMOTHORAX; POLYMERASE CHAIN REACTION; RESPIRATORY FAILURE; THORAX DRAINAGE; THORAX RADIOGRAPHY;

EID: 84880700959     PISSN: 1341321X     EISSN: 14377780     Source Type: Journal    
DOI: 10.1007/s10156-012-0473-9     Document Type: Article

References (20)

1. Greene RE, Schlamm HT, Oestmann JW, Stark P, Durand C, Lortholary O, et al. Imaging findings in acute invasive pulmonary aspergillosis: clinical significance of the halo sign. Clin Infect Dis. 2007;44:373-9.
2. Ohmagari N, Raad II, Hachem R, Kontoyiannis DP. Invasive aspergillosis in patients with solid tumors. Cancer (Phila). 2004;15:2300-2.
3. Segal BH. Aspergillosis. N Engl J Med. 2009;360:1870-84.
4. De Pauw B, Walsh TJ, Donnelly JP, Stevens DA, Edwards JE, Calandra T, et al. Revised definitions of invasive fungal disease from the European Organization for Research and Treatment of Cancer/Invasive Fungal Infections Cooperative Group and the National Institute of Allergy and Infectious Diseases Mycoses Study Group (EORTC/MSG) Consensus Group. Clin Infect Dis. 2008;46:1813-21.
5. Denning DW. Diagnosis and management of invasive aspergillosis. Curr Clin Top Infect Dis. 1996;16:277-99.
6. Vandewoude KH, Blot SI, Benoit D, Colardyn F, Vogelaers D. Invasive aspergillosis in critically ill patients: attributable mortality and excesses in length of ICU stay and ventilator dependence. J Hosp Infect. 2004;56:269-76.
7. Sepkowitz KA. Opportunistic infections in patients with and patients without acquired immunodeficiency syndrome. Clin Infect Dis. 2002;34:1098-107.
8. Festic E, Gajic O, Limper AH, Aksamit TR. Acute respiratory failure due to pneumocystis pneumonia in patients without human immunodeficiency virus infection: outcome and associated features. Chest. 2005;128:573-9.
9. Arend SM, Kroon FP, van't Wout JW. Pneumocystis carinii pneumonia in patients without AIDS, 1980 through 1993. An analysis of 78 cases. Arch Intern Med. 1993;1995(155):2436-41.
10. Catherinot E, Lanternier F, Bougnoux ME, Lecuit M, Couderc LJ, Lortholary O. Pneumocystis jirovecii pneumonia. Infect Dis Clin N Am. 2010;24:107-38.
11. Shankar EM, Kumarasamy N, Rajan R, Balakrishnan P, Solomon S, Devaleenol B, et al. Aspergillus fumigatus, Pneumocystis jirovecii, Klebsiella pneumoniae & Mycoplasma fermentans co-infection in a HIV infected patient with respiratory conditions from southern India. Indian J Med Res. 2006;123:181-4.
12. Worth LJ, Dooley MJ, Seymour JF, Mileshkin L, Slavin MA, Thursky KA. An analysis of the utilisation of chemoprophylaxis against Pneumocystis jirovecii pneumonia in patients with malignancy receiving corticosteroid therapy at a cancer hospital. Br J Cancer. 2005;92:867-72.
13. Dimopoulos G, Piagnerelli M, Berré J, Eddafali B, Salmon I, Vincent JL. Disseminated aspergillosis in intensive care unit patients: an autopsy study. J Chemother. 2003;15:71-5.
14. Rello J, Esandi ME, Mariscal D, Gallego M, Domingo C, Valles J. Invasive pulmonary aspergillosis in patients with chronic obstructive pulmonary disease: report of eight cases and review. Clin Infect Dis. 1998;26:1473-5.
15. Cornet M, Mallat H, Somme D, Guerot E, Kac G, Mainardi L, et al. Fulminant invasive pulmonary aspergillosis in immunocompetent patients: a two-case report. Clin Microbiol Infect. 2003;9:1224-7.
16. Kaira K, Shinomiya Y, Takahashi Y, Iida T, Yanagitani N, Sunaga N, et al. Coinfection of invasive pulmonary aspergillosis and Pneumocystis jirovecii pneumonia in a non-HIV patient. Acta Med Okayama. 2007;61:235-8.
17. Marinosa M, Soler A, Nogues X, Pedro-Botet J. Pulmonary coinfection by Pneumocystis carinii and Aspergillus fumigatus in a seronegative arthritis patient treated with low-dose methotrexate. Clin Rheumatol. 2004;23:555-6.
18. Lee T, Bae YJ, Park SK, Park HJ, Kim SH, Cho YS, et al. Severe pneumonia caused by combined infection with Pneumocystis carinii, parainfluenza virus type 3, cytomegalovirus and Aspergillus fumigatus in a patient with Stevens-Johnson syndrome/toxic epidermal necrolysis. Acta Derm Venereol. 2010;90:625-9.
19. Mansharamani NG, Garland R, Delaney D, Koziel H. Management and outcome patterns for adult Pneumocystis carinii pneumonia, 1985 to 1995: comparison of HIV-associated cases to other immunocompromised states. Chest. 2000;118:704-11.
20. Klein NC, Go CH, Cunha BA. Infections associated with steroid use. Infect Dis Clin N Am. 2001;15:423-32.